These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24807624)

  • 21. In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria.
    Grare M; Mourer M; Fontanay S; Regnouf-de-Vains JB; Finance C; Duval RE
    J Antimicrob Chemother; 2007 Sep; 60(3):575-81. PubMed ID: 17626025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
    Farrell DJ; Robbins M; Rhys-Williams W; Love WG
    Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis, and in vitro antimicrobial activity of hydrazide-hydrazones of 2-substituted acetic acid.
    Popiołek Ł; Biernasiuk A
    Chem Biol Drug Des; 2016 Dec; 88(6):873-883. PubMed ID: 27422854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antimicrobial potential of nitrofuran-triazole congeners.
    Kamal A; Hussaini SM; Sucharitha ML; Poornachandra Y; Sultana F; Ganesh Kumar C
    Org Biomol Chem; 2015 Sep; 13(36):9388-97. PubMed ID: 26238045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST).
    Bouchillon SK; Iredell JR; Barkham T; Lee K; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Feb; 33(2):130-6. PubMed ID: 18995992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial Activity of Cyclic-Monomeric and Dimeric Derivatives of the Snail-Derived Peptide Cm-p5 against Viral and Multidrug-Resistant Bacterial Strains.
    González-García M; Morales-Vicente F; Pico ED; Garay H; Rivera DG; Grieshober M; Raluca Olari L; Groß R; Conzelmann C; Krüger F; Zech F; Prelli Bozzo C; Müller JA; Zelikin A; Raber H; Kubiczek D; Rosenau F; Münch J; Stenger S; Spellerberg B; Franco OL; Rodriguez Alfonso AA; Ständker L; Otero-Gonzalez AJ
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity of six medicinal Cameroonian plants against Gram-positive and Gram-negative multidrug resistant phenotypes.
    Voukeng IK; Beng VP; Kuete V
    BMC Complement Altern Med; 2016 Oct; 16(1):388. PubMed ID: 27724917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro effects on biofilm viability and antibacterial and antiadherent activities of silymarin.
    Evren E; Yurtcu E
    Folia Microbiol (Praha); 2015 Jul; 60(4):351-6. PubMed ID: 25937395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the antibacterial potential of Petroselinum crispum and Rosmarinus officinalis against bacteria that cause urinary tract infections.
    Petrolini FV; Lucarini R; de Souza MG; Pires RH; Cunha WR; Martins CH
    Braz J Microbiol; 2013; 44(3):829-34. PubMed ID: 24516424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study.
    Betriu C; Rodríguez-Avial I; Gómez M; Culebras E; López F; Alvarez J; Picazo JJ;
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):437-44. PubMed ID: 16949245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxazolidinone antimicrobials: a patent review (2012-2015).
    Phillips OA; Sharaf LH
    Expert Opin Ther Pat; 2016 May; 26(5):591-605. PubMed ID: 26998627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changing trends in antimicrobial resistance of major bacterial pathogens, 1985-2005: a study from a medical center in northern Taiwan.
    Lo WT; Lin WJ; Chiueh TS; Lee SY; Wang CC; Lu JJ
    J Microbiol Immunol Infect; 2011 Apr; 44(2):131-8. PubMed ID: 21439516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Derivatives of aryl-4-guanidinomethylbenzoate and N-aryl-4-guanidinomethylbenzamide as new antibacterial agents: synthesis and bioactivity.
    Yu WY; Yang LX; Xie JS; Zhou L; Jiang XY; Zhu DX; Muramatsu M; Wang MW
    Acta Pharmacol Sin; 2008 Feb; 29(2):267-77. PubMed ID: 18215358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections.
    Younis W; Thangamani S; Seleem MN
    Curr Pharm Des; 2015; 21(28):4106-11. PubMed ID: 25961308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. meso-Dihydroguaiaretic acid derivatives with antibacterial and antimycobacterial activity.
    Reyes-Melo K; García A; Romo-Mancillas A; Garza-González E; Rivas-Galindo VM; Miranda LD; Vargas-Villarreal J; Favela-Hernández JMJ; Camacho-Corona MDR
    Bioorg Med Chem; 2017 Oct; 25(20):5247-5259. PubMed ID: 28844400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of peptoid mimics of short, lipophilic peptide antimicrobials.
    Green RM; Bicker KL
    Int J Antimicrob Agents; 2020 Aug; 56(2):106048. PubMed ID: 32540430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ; Park CH
    Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial activity of Ilex paraguariensis (Yerba Mate) against Gram-positive and Gram-negative bacteria.
    Noureddine T; El Husseini Z; Nehme A; Abdel Massih R
    J Infect Dev Ctries; 2018 Sep; 12(9):712-719. PubMed ID: 31999628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011.
    Kanj SS; Whitelaw A; Dowzicky MJ
    Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.